Pfizer Vaccine Delivery Could Start "Before Christmas, If All Goes Well" | Read
PUBLISHED ON: November 19, 2020 | Duration: 0 min, 23 sec
Pfizer Inc and BioNTech could secure emergency US and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.
